期刊文献+

4种抗真菌药物对糖尿病大鼠血糖的影响 被引量:4

Effects of 4 antifungal agents on the blood glucose level of diabetic rats
下载PDF
导出
摘要 目的观察酮康唑、氟康唑、伊曲康唑和特比萘芬与胰岛素组合使用以及单独使用时对糖尿病大鼠血糖水平的影响。方法建立糖尿病大鼠模型,随机分为10组,每组5只。前4组皮下注射胰岛素的同时分别喂食4种抗真菌药物;第5组单独皮下注射胰岛素;第6~9组分别喂食4种抗真菌药物;第10组既不注射胰岛素也不喂食抗真菌药物。定时对糖尿病大鼠尾静脉采血,使用CX5PRO生化检测仪对其血糖进行检测。结果酮康唑、氟康唑和伊曲康唑分别与胰岛素合用时,可使糖尿病大鼠血糖降低(P<0.05);不与胰岛素合用时,氟康唑和伊曲康唑均可使糖尿病大鼠血糖升高(P<0.05);特比萘芬无论是否与胰岛素合用,对糖尿病大鼠的血糖水平均无影响(P>0.05)。结论唑类抗真菌药物无论是否与胰岛素合用均会影响糖尿病大鼠的血糖水平,特比萘芬无论是否与胰岛素合用,都不会影响糖尿病大鼠的血糖水平。 Objective To investigate the blood glucose level of diabetic rats treated with four different antifungal agents,ketoconazole,fluconazole, itraconazole and terbinafine with or without insulin. Methods Diabetes mellitus model was set up in 50 SD rats and divided into 10 groups. Rats in group 1 to 4 were administered with insulin and 4 antifungal drugs, separately. Rats in group 5 were administered with insulin injection only. Rats in group 6 to 9 were fed with 4 antifungal agents without any injection. The last 5 rats were treated as control. The blood glucose levels were determined at different time intervals. Results The blood glucose level dropped down when the rats treated with insulin combined with ketoconazole,fluconazole or itraeonazole ( P 〈 0.05 ) ,while rose up in fluconazole and itraconazole group without insulin injection ( P 〈 0.05 ). Terbinafine had no effects on the blood glucose level of diabetic rat whether insulin was given or not ( P 〉 0.05 ). Conclusions Azole antifungal agents have potential influence on the blood glucose level of diabetic rats, but terbinafine has no effect with or without insulin injection.
作者 向谦 郑捷
出处 《中国真菌学杂志》 2009年第3期140-143,共4页 Chinese Journal of Mycology
关键词 糖尿病 抗真菌药 血糖 diabetes mellitus antifungal agents blood glucose
  • 相关文献

参考文献4

二级参考文献13

共引文献33

同被引文献37

  • 1周峥,肖正华,曾军.糖尿病合并呼吸道深部真菌感染危险因素的分析[J].实用医学杂志,2005,21(15):1662-1663. 被引量:13
  • 2GavaldaJ,LenO,SanJuanR,et al.Risk factors for invasive aspergillosisinsolid-organ transplantre cipients:Acase-controlstudy[J].ClinIn fect Dis,2005,41:52-9.
  • 3Kauffman CA,Vazquez JA,Sobel JD,et al.Prospective multicen-ter surveillance study of funguria in hospitalized patients[J].ClinInfect Dis,2000,30(1):14-18.
  • 4Herbrechtr R,Denning D W,Patterson T F,et al.Voriconazole versus amphotericin B for primary therapy of invasive as pergillosis[J].N Engl J Med,2002,347(6):408-415.
  • 5Goswami R, Dadhwal V, Tejaswi S, et al. Species-specific prevalence of vaginal candidiasis among patients with diabetes mellitus and its relation to their glycaemic status. J Infect,2000,41 (2):162-166.
  • 6Matricciani L, Talbot K, Jones S. Safety and efficacy of tinea pedis and onychomycesis treatment in people with diabetes: a systematic review. J Foot Ankle Res,2011,4:26.
  • 7Brenner MA, Harkless LB, Mendieino RW, et al. Ciclopirox 8% nail lacquer topical solution for the treatment of onychomycesis in patients with diabetes: a muhicenter, open-label study. J Am Podiatr Med Assoe, 2007,97 (3) : 195-202.
  • 8陈灏珠.实用内科学11版[M].北京:人民卫生出版社,2001.1549-1550.
  • 9谢志宏,姚志远,李邻峰,刘永生,孙秋宁,郑占才,尤立平,马蕾,宋佩华.特比萘芬治疗糖尿病患者甲真菌病疗效和对血糖水平的影响[J].中国麻风皮肤病杂志,2007,23(9):773-775. 被引量:4
  • 10熊璐琪.糖尿病大鼠皮肤的组织学改变对不同脂溶性的地塞米松经皮渗透与吸收的影响[D].深圳:南方科技大学,2011.

引证文献4

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部